Guanidinoacetate methyltransferase (GAMT) deficiency is an autosomal recessively inherited disorder
INTRODUCTION
Guanidinoacetate methyltransferase (GAMT) deficiency is an autosomal recessively inherited disorder of creatine biosynthesis (Stö ckler et al., 1994 (Stö ckler et al., , 1996b von Figura et al., 2001) . GAMT deficiency manifests during the first months of life as a developmental delay or arrest. Neurological symptoms are heterogeneous, including muscular hypotonia and weakness, poor head control, involuntary extrapyramidal movements, epilepsy, and autistic or self-aggressive behavior in older patients (Ganesan et al., 1997; Leuzzi et al., 2000; Schulze et al., 1997; Stö ckler et al., 1994 Stö ckler et al., , 1996b von Figura et al., 2001) . Abnormal signal intensities in the globus pallidus, as observed on magnetic resonance imaging (MRI) scans, may provide an important clue for diagnosis. The diagnosis of the disease is based on the detection of excessive amounts of guanidinoacetate (GAA) in urine, serum, and cerebrospinal fluid (CSF), the deficiency of creatine/phosphocreatine in brain magnetic resonance spectroscopy, and the absence of GAMT activity in fibroblasts or lymphocytes (Ilas et al., 2000; Leuzzi et al., 2000; Stö ckler et al., 1994 Stö ckler et al., , 1997 .
Creatine is synthesized in a two-step mechanism from glycine, arginine, and methionine. In a first ratelimiting reaction, GAA and ornithine are formed by arginine:glycine amidinotransferase. In a second reaction, catalyzed by GAMT, S-adenosylmethionine do-
